Virginia Retirement Systems’s Intellia Therapeutics NTLA Stock Holding History

Virginia Retirement Systems’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$192K	Buy	21,342 +4,600	+27%	+$63.3K	﹤0.01%	919
2025 Q3	$289K	Sell	16,742 -1,000	-6%	-$12.3K	﹤0.01%	847
2025 Q2	$166K	Buy	17,742 +900	+5%	+$7.39K	﹤0.01%	912
2025 Q1	$120K	Buy	+16,842	New	+$170K	﹤0.01%	991
2023 Q3	–	Sell	-8,600	Closed	-$351K	–	1004
2023 Q2	$351K	Buy	8,600 +1,700	+25%	+$68.9K	﹤0.01%	806
2023 Q1	$257K	Buy	+6,900	New	+$271K	﹤0.01%	914
2022 Q1	–	Sell	-4,200	Closed	-$497	–	1189
2021 Q4	$497	Sell	4,200 -4,800	-53%	-$601K	﹤0.01%	855
2021 Q3	$1.21M	Sell	9,000 -1,000	-10%	-$151K	0.01%	555
2021 Q2	$1.62M	Sell	10,000 -1,500	-13%	-$117K	0.02%	487
2021 Q1	$923K	Buy	11,500 +2,000	+21%	+$134K	0.01%	687
2020 Q4	$517K	Buy	+9,500	New	+$345K	0.01%	835

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virginia Retirement Systems's NTLA Position: Q4 2025 in Review

Virginia Retirement Systems increased its Intellia Therapeutics (NTLA) stake by 27% in Q4 2025, buying an estimated $63.3K and bringing the position to 21,342 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #919.

Virginia Retirement Systems first reported a position in NTLA in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.62M in Q2 2021. 291 funds tracked by Wall St. Rank hold NTLA as of Q4 2025.

Virginia Retirement Systems held 21,342 shares of Intellia Therapeutics worth $192K as of Q4 2025.
Virginia Retirement Systems bought 4,600 Intellia Therapeutics shares in Q4 2025, an estimated $63.3K.
Intellia Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #919 holding.
Virginia Retirement Systems first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 11 quarters since.
Virginia Retirement Systems's Intellia Therapeutics position peaked at $1.62M in Q2 2021.
291 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.